Wordt geladen...
Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
CD19 Chimeric antigen receptor (CAR) T cell therapy has been shown to be effective for B cell leukemia and lymphoma. Many researchers are now trying to develop CAR T cells for various types of cancer. For multiple myeloma (MM), B-cell maturation antigen (BCMA) has been recently proved to be a promis...
Bewaard in:
| Gepubliceerd in: | Cancers (Basel) |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966463/ https://ncbi.nlm.nih.gov/pubmed/31847470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11122024 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|